Taxa de sudorese em atletas de judô

O judô é um esporte de combate praticado como arte marcial e estabelece formas de desenvolvimento de técnicas de defesas pessoais. A desidratação neste esporte pode ser leve, moderada e grave e a taxa de sudorese de um atleta depende necessariamente de variáveis como intensidade do exercício, superfície corporal, temperatura ambiente, umidade e aclimatação. O objetivo do presente estudo foi avaliar a taxa de sudorese de atletas de judô. Trata-se de um estudo transversal de caráter experimental realizado com 35 atletas, com idade entre 9 e 34 anos, da equipe de judô de um clube na cidade de São Paulo.  Foi identificado que o percentual de perda de peso médio foi de 0,8% para os adultos e 0,1% para os adolescentes. Já o volume médio ingerido de líquidos durante o treino de aproximadamente 90 minutos, foi maior nos adolescentes (558 ml) do que nos adultos (393 ml). A média da taxa de sudorese dos adolescentes foi de 8,9 ml/min e dos adultos foi de 11,4 ml/min. Conclui-se que a perda de peso durante o treino e a taxa de sudorese em atletas de judô foi maior nos adultos do que nos adolescentes. A ingestão média de água pelos adultos foi menor em relação aos adolescentes, sendo que nenhum dos grupos consumiu a quantidade recomendada por hora de ingestão hídrica. No entanto, a perda de peso esteve dentro do aceitável, em ambos os grupos. ABSTRACTSweating rate in Judo athletesJudo is a combat sport practiced as a martial art and establishes forms of development of personal defense techniques. Dehydration in this sport can be mild, moderate and severe and the sweat rate of an athlete necessarily depend on such variables as exercise intensity, body surface, room temperature, humidity and acclimatization. The aim of this study was to evaluate the sweat rate of judo athletes. It is a cross-sectional study conducted experimentally with 35 athletes, aged 9 to 34 years old, from the judo team of a club in São Paulo. It was identified that the average weight loss percentage was 0.8% for adults and 0.1% for teens. The average volume of fluid ingested during training of about 90 minutes was higher in adolescents (558 ml) than in adults (393 ml). The average adolescents sweat rate was 8.9 ml / min and adults was 11.4 ml / min. We conclude that weight loss during training and the sweat rate in judo athletes was higher in adults than in teenagers. The average water intake by adults was lower when compared to adolescents, and neither group consumed the recommended amount of water intake per hour. However, weight loss was within the acceptable in both groups

Taxa de sudorese em atletas de judô

O judô é um esporte de combate praticado como arte marcial e estabelece formas de desenvolvimento de técnicas de defesas pessoais. A desidratação neste esporte pode ser leve, moderada e grave e a taxa de sudorese de um atleta depende necessariamente de variáveis como intensidade do exercício, superfície corporal, temperatura ambiente, umidade e aclimatação. O objetivo do presente estudo foi avaliar a taxa de sudorese de atletas de judô. Trata-se de um estudo transversal de caráter experimental realizado com 35 atletas, com idade entre 9 e 34 anos, da equipe de judô de um clube na cidade de São Paulo.  Foi identificado que o percentual de perda de peso médio foi de 0,8% para os adultos e 0,1% para os adolescentes. Já o volume médio ingerido de líquidos durante o treino de aproximadamente 90 minutos, foi maior nos adolescentes (558 ml) do que nos adultos (393 ml). A média da taxa de sudorese dos adolescentes foi de 8,9 ml/min e dos adultos foi de 11,4 ml/min. Conclui-se que a perda de peso durante o treino e a taxa de sudorese em atletas de judô foi maior nos adultos do que nos adolescentes. A ingestão média de água pelos adultos foi menor em relação aos adolescentes, sendo que nenhum dos grupos consumiu a quantidade recomendada por hora de ingestão hídrica. No entanto, a perda de peso esteve dentro do aceitável, em ambos os grupos. ABSTRACTSweating rate in Judo athletesJudo is a combat sport practiced as a martial art and establishes forms of development of personal defense techniques. Dehydration in this sport can be mild, moderate and severe and the sweat rate of an athlete necessarily depend on such variables as exercise intensity, body surface, room temperature, humidity and acclimatization. The aim of this study was to evaluate the sweat rate of judo athletes. It is a cross-sectional study conducted experimentally with 35 athletes, aged 9 to 34 years old, from the judo team of a club in São Paulo. It was identified that the average weight loss percentage was 0.8% for adults and 0.1% for teens. The average volume of fluid ingested during training of about 90 minutes was higher in adolescents (558 ml) than in adults (393 ml). The average adolescents sweat rate was 8.9 ml / min and adults was 11.4 ml / min. We conclude that weight loss during training and the sweat rate in judo athletes was higher in adults than in teenagers. The average water intake by adults was lower when compared to adolescents, and neither group consumed the recommended amount of water intake per hour. However, weight loss was within the acceptable in both groups

Empagliflozin in Patients with Chronic Kidney Disease

Background The effects of empagliflozin in patients with chronic kidney disease who are at risk for disease progression are not well understood. The EMPA-KIDNEY trial was designed to assess the effects of treatment with empagliflozin in a broad range of such patients. Methods We enrolled patients with chronic kidney disease who had an estimated glomerular filtration rate (eGFR) of at least 20 but less than 45 ml per minute per 1.73 m(2) of body-surface area, or who had an eGFR of at least 45 but less than 90 ml per minute per 1.73 m(2) with a urinary albumin-to-creatinine ratio (with albumin measured in milligrams and creatinine measured in grams) of at least 200. Patients were randomly assigned to receive empagliflozin (10 mg once daily) or matching placebo. The primary outcome was a composite of progression of kidney disease (defined as end-stage kidney disease, a sustained decrease in eGFR to < 10 ml per minute per 1.73 m(2), a sustained decrease in eGFR of & GE;40% from baseline, or death from renal causes) or death from cardiovascular causes. Results A total of 6609 patients underwent randomization. During a median of 2.0 years of follow-up, progression of kidney disease or death from cardiovascular causes occurred in 432 of 3304 patients (13.1%) in the empagliflozin group and in 558 of 3305 patients (16.9%) in the placebo group (hazard ratio, 0.72; 95% confidence interval [CI], 0.64 to 0.82; P < 0.001). Results were consistent among patients with or without diabetes and across subgroups defined according to eGFR ranges. The rate of hospitalization from any cause was lower in the empagliflozin group than in the placebo group (hazard ratio, 0.86; 95% CI, 0.78 to 0.95; P=0.003), but there were no significant between-group differences with respect to the composite outcome of hospitalization for heart failure or death from cardiovascular causes (which occurred in 4.0% in the empagliflozin group and 4.6% in the placebo group) or death from any cause (in 4.5% and 5.1%, respectively). The rates of serious adverse events were similar in the two groups. Conclusions Among a wide range of patients with chronic kidney disease who were at risk for disease progression, empagliflozin therapy led to a lower risk of progression of kidney disease or death from cardiovascular causes than placebo